End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation

Movement Disorders

Volumn 21, Issue 8, 2006, Pages 1277-1279

  Apetauerova, Diana ^a   Ryan, R Kevin ^b   Ro, Susie I ^b   Arle, Jeffrey ^a   Shils, Jay ^a   Papavassiliou, Efstathios ^b   Tarsy, Daniel ^b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

DBS; Deep brain stimulation; End of dose dyskinesia; Parkinson's disease

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PRAMIPEXOLE;

ADULT; ARTICLE; BRADYKINESIA; BRAIN DEPTH STIMULATION; CASE REPORT; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; FEMALE; GLOBUS PALLIDUS; HUMAN; MICROELECTRODE; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SUBTHALAMIC NUCLEUS; TREMOR;

DEEP BRAIN STIMULATION; DYSKINESIAS; FEMALE; FUNCTIONAL LATERALITY; GLOBUS PALLIDUS; HUMANS; MIDDLE AGED; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 33748351612     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20896     Document Type: Article

References (12)

1. Muenter MD, Sharpless NS, Tyce GM, Darly FL. Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-dopa therapy for Parkinson's disease. Mayo Clin Proc 1977;52:163-174.
2. Luquin MR, Scipioni O, Vaamonde J, Gershanik O, Obeso J. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Mov Disord 1992;7:117-124.
3. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol 2000;47(Suppl. 1):S2-S11.
4. Marsden CD, Parkes JD, Quinn N. Fluctuations of disability in Parkinson's disease-clinical aspects. In: Marsden CD, Fahn S, editors. Movement disorders. London: Butterworth; 1982. p 96-122.
5. Zimmerman TR, Sage JI, Lang AE, Mark MH. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment. Mov Disord 1994;9: 173-177.
6. Lhermitte F, Agid Y, Signoret JL. Onset and end-of-dose levodopa-induced dyakinesias. Arch Neurol 1978;35:261-263.
7. The deep-brain stimulation for Parkinson's disease study group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
8. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain 1999;122: 1133-1146.
9. Ostergard K, Sunde N, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 2002;17:693-700.
10. Krack P, Pollak P, Limousin P, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998;43: 180-192.
11. Russman H, Ghika J, Combrement P, et al. L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction. Neurology 2004;63:153-155.
12. Alterman RL, Shils JL, Gudesblatt M, Tagliati M. Immediate and sustained relief of levodopa-induced dyskinesias after dorsal relocation of a deep brain stimulation lead. Neurosurg Focus 2004;17: 39-42.